Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

EuroIntervention 2016;12:e584-e594 published online e-edition August 2016. DOI: 10.4244/EIJV12I5A98

Wijnand Stuijfzand
Wijnand J. Stuijfzand1, MD; Pieter G. Raijmakers2, MD, PhD; Roel S. Driessen1, MD; Adriaan A. Lammertsma2, PhD; Albert C. van Rossum1, MD, PhD; Alexander Nap1, MD, PhD; Yolande Appelman1, MD, PhD; Jorrit S. Lemkes1, MD; Maarten A. van Leeuwen1, MD; Niels van Royen1, MD, PhD; Paul Knaapen1*, MD, PhD
1. Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands; 2. Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

Aims: A randomised clinical trial of bioresorbable vascular scaffold (BVS) vs. metal drug-eluting stent (DES) was initiated, using positron emission tomography (PET) perfusion imaging to

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbable vascular scaffoldcold pressor testcoronary flow reservemyocardial blood flowpercutaneous coronary interventionpositron emission tomography
Coronary interventionsStents and scaffoldsInvasive imaging and functional assessment
Read next article
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

Latest news